NCT04316546 2026-03-11MK-7075 (Miransertib) in Proteus SyndromeNational Institutes of Health Clinical Center (CC)Phase 2 Recruiting45 enrolled
NCT02594215 2022-06-30Dose Finding Trial of MK-7075 in Children and Adults With Proteus SyndromeNational Institutes of Health Clinical Center (CC)Phase 1 Completed6 enrolled